NCT07051252 - A Study of HBS-201 (Pitolisant Delayed-release) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Narcolepsy

Interventions

DRUG

HBS-201

On Days 1-7, participants will take HBS-201 17.8 mg per day (one 17.8 mg tablet) and on Days 8-14, participants will take HBS-201 35.6 mg per day (two 17.8 mg tablets).

Trial Locations (15)

19610

RECRUITING

Harmony Site 15, Wyomissing

26506

NOT_YET_RECRUITING

Harmony Site 7, Morgantown

28037

RECRUITING

Harmony Site 10, Denver

28078

RECRUITING

Harmony Site 2, Huntersville

29201

RECRUITING

Harmony Site 5, Columbia

29406

RECRUITING

Harmony Site 12, North Charleston

30328

RECRUITING

Harmony Site 8, Atlanta

33176

RECRUITING

Harmony Site 4, Miami

33511

RECRUITING

Harmony Site 14, Brandon

44718

RECRUITING

Harmony Site 6, Canton

45245

RECRUITING

Harmony Site 1, Cincinnati

48085

RECRUITING

Harmony Site 11, Troy

78731

RECRUITING

Harmony Site 3, Austin

94583

RECRUITING

Harmony Site 9, San Ramon

02459

RECRUITING

Harmony Site 13, Newton

All Listed Sponsors

lead

Harmony Biosciences Management, Inc.

INDUSTRY